ProAssurance faces challenges in medical malpractice insurance, but shows improvement in net income. See why I rate PRA stock ...
According to the average brokerage recommendation (ABR), one should invest in Celestica (CLS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' ...
Devon Energy is a compelling long-term investment with new acreage, share buybacks, and strong profitability despite lower ...
The early weeks of January are a wonderful time to reshuffle your stock portfolio and buy great stocks with big long-term ...
Foghorn Therapeutics Inc. (FHTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...
Analysts have mixed opinions on BMY, with a “Moderate Buy” consensus from 25 analysts. Seven rate it a “Strong Buy,” 17 recommend “Hold,” and one suggests “Sell.” The average price target is $59.52, ...
Here are four Buy-rated financial stocks with the highest dividend yields that can boost investors' total return potential.
A Nomura note said competitive intensity from D2C brands may ease and quick commerce could act as a tailwind to spur demand ...
We recently published a list of 10 Best Single Digit Stocks To Buy Now. In this article, we are going to take a look at where ...
TCS valuations stay attractive compared with peers Infosys Ltd and HCL Technologies Ltd, analysts said as they suggested 'Buy ...
These stocks were down in the range of 1 per cent to 3 per cent in intra-day trades. They have corrected by up to 35 per cent ...